Opioid MDL Special Master Sets Data Production Guidelines

Law360 (January 28, 2020, 6:25 PM EST) -- A special master in the opioid multidistrict litigation in Ohio on Monday outlined what data pharmacies have to turn over to local governments in the litigation, including information on non-opioids that are associated with "doctor-shopping."

Special Master David Cohen said that the pharmacies have to produce data for 14 benzodiazepines and four muscle relaxers, along with the prescription data for opioids. According to the Ohio Board of Pharmacy, the most glaring "red flag" combinations involve mixing opioids with a benzodiazepine and a muscle relaxer, Cohen said.

The pharmacies had previously agreed to release data for a sedative called alprazolam and for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!